Our formulas are developed and continuously reviewed by a multidisciplinary team of clinicians, PhDs, and independent advisors. The team’s oversight spans formulation, clinical research, and ongoing scrutiny of the emerging science, so that our product evolves as science emerges.
Our experts have authored or contributed to over 500 research studies and abstract publications in top-tier, high-impact scientific journals.
The Research and Development Team and our Science and Innovation Board include researchers and clinicians trained at top-tier medical, kinesiology, nutrition, and food science institutions across the country.
The Research and Development Teams have supported the development of more than 250 dietary supplements, technologies, and health applications to advance nutrition science.
Our in-house team of clinicians, scientists, and formulators brings diverse expertise across nutrition, metabolism, microbiome, food science, and related fields. We also collaborate with independent experts, academic institutions, and clinical partners to advance research and expand our understanding with cutting-edge technology.
Our independent Science and Innovation Advisors bring deep expertise across nutrition science, health, and research. They work alongside our in-house team to provide guidance on research and product development, helping to ensure our work remains rigorous, forward-looking, and grounded in evidence.
Beyond sharing our findings online and at national conferences, we work with leading researchers to submit study manuscripts to peer-reviewed scientific journals—contributing to the broader scientific dialogue on the vital role of nutrition and the microbiome in overall health.
Authors: Adam M. Gonzalez, Jeremy R. Townsend, Philip A. Sapp, Caitlyn Edwards, Trevor O. Kirby, Justin Wright, Regina Lamendella, and Ralph Esposito
Journal and Year: Frontiers in Nutrition 2026
Study Type: Randomized, double-blind, placebo-controlled crossover study
Contribution: Authors consist of academic faculty from Hofstra, external scientists, and members of the AG1 scientific and research team
Key observations: A 2-week crossover clinical trial including 20 healthy, physically active, adults found that AG1® supplementation was associated with selective enrichment of key bacterial taxa, including Lactiplantibacillus plantarum, Lacticaseibacillus rhamnosus, and Bifidobacterium animalis. AG1® supplementation significantly improved nutritional adequacy by increasing the total number of micronutrient Estimated Average Requirements (EARs) met compared to placebo. Vitamins A, C, and E were the most common nutrient gaps filled by AG1 supplementation.
